Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Vaccines|February 26, 2022
Comparative Immunogenicity of COVID-19 Vaccines in a Population-Based Cohort Study with SARS-CoV-2-Infected and Uninfected ParticipantsDavid Peterhoff, Sebastian Einhauser, Stephanie Beileke, et al.
Frontiers in Immunology|January 11, 2020
Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune ResponsesBeatriz Perdiguero, Carmen Elena Gómez, Juan García-Arriaza, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2021
A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entryJulián Valero, Laia Civit, Daniel M Dupont, et al.
Frontiers in Immunology|December 4, 2023
Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env proteinBeatriz Perdiguero, Alexandra Hauser, Carmen Elena Gómez, et al.
Journal of Virology|May 8, 2021
SARS-CoV-2 Spike Protein Stabilized in the Closed State Induces Potent Neutralizing ResponsesGeorge W Carnell, Katarzyna A Ciazynska, David A Wells, et al.
Ebiomedicine|November 10, 2024
Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responsesSebastian Einhauser, Claudia Asam, Manuela Weps, et al.
Journal of Virology|October 31, 2014
Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particlesBeatriz Perdiguero, Carmen Elena Gómez, Victoria Cepeda, et al.
Vaccines|August 6, 2021
Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen SelectionJoanne Marie M Del Rosario, Kelly A S da Costa, Benedikt Asbach, et al.
The Journal of General Virology|October 6, 2025
Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccineMartina Pfranger, Nina Krause, Benedikt Asbach, et al.
Cell Reports. Medicine|February 2, 2022
Antibodies against viral nucleo-, phospho-, and X protein contribute to serological diagnosis of fatal Borna disease virus 1 infectionsBernhard Neumann, Klemens Angstwurm, Ralf A Linker, et al.
Pageof 4